- Report
- May 2022
- 120 Pages
Global
From €4142EUR$4,450USD£3,464GBP
- Report
- July 2024
- 201 Pages
Global
From €4649EUR$4,995USD£3,888GBP
- Report
- May 2026
- 150 Pages
Australia
From €4514EUR$4,850USD£3,775GBP
- Report
- May 2026
- 150 Pages
Brazil
From €4514EUR$4,850USD£3,775GBP
- Report
- May 2026
- 150 Pages
Canada
From €4514EUR$4,850USD£3,775GBP
- Report
- August 2025
- 150 Pages
Global
From €4514EUR$4,850USD£3,775GBP
- Report
- November 2024
- 150 Pages
Global
From €4514EUR$4,850USD£3,775GBP
- Report
- October 2025
- 160 Pages
Global
From €2941EUR$3,160USD£2,460GBP
€3676EUR$3,950USD£3,074GBP
- Report
- October 2025
- 160 Pages
Global
From €2941EUR$3,160USD£2,460GBP
€3676EUR$3,950USD£3,074GBP
- Report
- October 2025
- 160 Pages
Global
From €2941EUR$3,160USD£2,460GBP
€3676EUR$3,950USD£3,074GBP
- Report
- October 2025
- 160 Pages
Global
From €2941EUR$3,160USD£2,460GBP
€3676EUR$3,950USD£3,074GBP
- Report
- December 2024
- 150 Pages
Global
From €2941EUR$3,160USD£2,460GBP
€3676EUR$3,950USD£3,074GBP
- Report
- November 2022
- 224 Pages
Global
From €3350EUR$3,600USD£2,802GBP
- Report
- November 2022
- 89 Pages
Asia Pacific
From €1396EUR$1,500USD£1,168GBP
- Report
- November 2022
- 78 Pages
North America
From €1396EUR$1,500USD£1,168GBP
- Report
- April 2024
- 100 Pages
Africa
From €1861EUR$2,000USD£1,557GBP
From €1396EUR$1,500USD£1,168GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1396EUR$1,500USD£1,168GBP
- Report
- April 2024
- 80 Pages
United States
From €1396EUR$1,500USD£1,168GBP
- Report
- April 2024
- 80 Pages
China
From €1396EUR$1,500USD£1,168GBP

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically.
The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer.
In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more